Evidence that has been or should be considered for guidelines on antihypertensive treatment

International Journal of Clinical Practice

Volumn , Issue SUPPL. 92, 1997, Pages 8-12

  Mancia, Giuseppe ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ANTIHYPERTENSIVE THERAPY; CONFERENCE PAPER; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; KIDNEY INJURY; PRACTICE GUIDELINE; PRIORITY JOURNAL;

EID: 33749284836     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Mancia G, Mangoni AA, Pailla M, Rivolta MR. Guidelines for the treatment of hypertension: a commentary. Curr Ther Res 1996; 57: 3-15.
2. Joint National Committee. Report on detection, evaluation and treatment of high blood pressure. JAMA 1977; 237: 255-261.
3. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressure averaging 90 through 114 mmHg. JAMA 1970; 213: 1143-1152.
4. Joint National Committee on detection, evaluation and treatment of high blood pressure. The fifth Report of the Joint National Committee on detection, evaluation and treatment of high blood pressure (JNC V). Arch Intern Med 1993; 153: 154-183.
5. Joint National Committee. The 1988 report of the Joint National Committee on detection, evaluation and treatment of high blood pressure. Arch Intern Med 1988; 148: 1023-1038.
6. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255-3264.
7. WHO Expert Committee. Arterial hypertension. Technical report series No. 628. Geneva: World Health Organization 1978.
8. Medical Research Council Working Party. MRC trial of treatment of mild hypertension. Principal results. BMJ 1985; 291: 97-104.
9. Laragh JH, Letcher RL, Pickering TG. Renin profiling for diagnosis and treatment of hypertension. JAMA 1979; 241: 151-156.
10. Guidelines Subcommittee of the WHO/ISH Mild Hypertension Liaison Committee. 1989 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. J Hypertens 1989; 7: 689-693.
11. Hypertension, Detection and Follow-up Program Cooperative Group. Patient participation in a hypertension control program. JAMA 1978; 239: 1507-1514.
12. The Management Committee. The Australian therapeutic trial in mild hypertension. Lancet 1980; i: 1261-1267.
13. Guidelines Subcommittee of the WHO/ISH Mild Hypertension Liaison Committee. 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. J Hypertens 1993; 11: 905-918.
14. Hansson L, Dahlof B. What are we achieving with long-term antihypertensive drug therapy? In: Laragh JH, Brenner BM (eds). Hypertension: Pathophysiology, Diagnosis and Management. New York: Raven Press, 1990, 2131-2142.
15. Mancia G, Grassi G. Editorial: Combination treatment in antihypertensive drug trials. Cardiovasc Drug Ther 1997: in press.
16. Amery A, Birkenhager W, Brixko P, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet 1985; i: 1349-1354.
17. Isles CG, Walker LM, Beevers GD, et al. Mortality in patients of the Glasgow Blood Pressure Clinic. J Hypertens 1986; 4: 141 -156.
18. Mayers LC, Horwitz RJ, Feinstein AR. A collection of 56 topics with contradictory results in case-control research. Int J Epidemiol 1986; 17: 680-685.
19. Horwik RJ, Feinstein AR. Exclusion bias and the false relationship of reserpine and breast cancer. Arch Intern Med 1985; 145: 1873-1875.
20. Psaty BM, Heckbert SR, Koepsell TD, et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995; 274: 620-625.
21. Pahor M, Guralnik JM, Salive ME, Cortis MC, Carbonin P, Haviik RJ. Do calcium channel blockers increase the risk of cancer? Am J Hypertens 1986; 9: 695-699.
22. Pahor M, Guralnik JM, Furberg CD, Carbonin N, Haviik RJ. Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old. Lancer 1996; 374: 1061-1065.
23. Mancia G, Van Zwieten PA. How safe are calcium antagonists in hypertension and coronary heart disease? J Hypertens 1996; 14: 13-17.
24. Ad Hoc Subcommittee of the Liaison Committee of the World Health Organization and the International Society of Hypertension. Affects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding. J Hypertens 1997; 15: 105-115.
25. Gong L, Zhang W, Zhu Y, Zhu J, Kong D, Page V, et al. Shangai Trial of Nifedipine in the Elderly (STONE). J Hypertens 1996; 14: 1237-1245.
26. Staessen J on behalf of the investigators. The systolic hypertension in Europe trial (Syst-Eur). Principal results. Proc VIII Meet European Society of Hypertension, Milano, 1997.
27. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD.The effect of angiotensin converting enzyme inhibition on , diabetic nephropathy. The collaborative study group. N Engl J Med 1993; 329: 1456-1462.
28. Parving HH, Andersen AR, Smidt UM, Homel E, Mathiesen ER, Svendsen PA. Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J 1987; 294: 1443-1447.
29. Casale PN, Devereux RB. Milner M, Zullo G, Harshfield GA, Pickering TG et al. Valve of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986; 105: 173-178.
30. Muiesan ML, Salvetti M, Rizzoni D, Castellano M, Donato F, Agabiti Rosei E. Association of changes in left ventricular mass with prognosis during long-term antihypertensive treatment. J Hypertens 1995; 13: 1091-1095.
31. O'Leary DH, Polak JF, Kronmal RA, Kittner SJ, Bond MG, Wolfson SK et al. Distribution and correlates of sonographically detected carotid artery disease in the cardiovascular health study. Stroke 1992; 23: 1752-1760.
32. Salonen R, Salonen JT. Carotid atherosclerosis in relation to systolic and diastolic blood pressure: Kuopio Ischaemic Heart Disease Risk Factor Study. Ann Med 1991; 23: 23-27.
33. Sytkowski PA, D'Agostino RB, Belanger AJ, Kännel WB. Secular trends in long-term sustained hypertension, long-term treatment and cardiovascular mortality. The Framingham Study 1950 to 1990. Circulation 1996; 93: 697-703.